drugset

drugset / Trial / NCT00667173

A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea

NCT00667173 ↗

Phase 2 Completed 140 enrolled Dow Pharmaceutical Sciences

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.

Timeline

Start: 2007-11
Primary completion: 2008-07
Completion: 2008-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IDP-115	Unknown	—	Topical

Indications